Interestingly, a recent study in rats reported that the spore-based probiotic, MegasporebioticTM, lowered serum ICAM-1 levels and, to a lesser extent, lowered serum VCAM-1 levels in the context of inflammatory bowel disease (IBD) [32]. The gene discussed is VCAM1; the disease is inflammatory bowel disease.